Glossary

Octenidine terms in plain language

Definitions for the names, evidence terms, safety language, and regulatory concepts used across the site.

Last reviewed
2026-05-07
Reviewed by
Octenidine.org Editorial Team

All readers

Octenidine

The active moiety name often used in scientific discussion of octenidine-containing substances or products.

A shorter name that may appear in articles, labels, and studies, but it should not erase formulation differences.
Primary source
PubChem, National Library of Medicine

All readers

Antiseptic

A substance or product used to reduce microorganisms on living tissue when used as directed for an approved or intended context.

An antiseptic is not the same as an antibiotic, disinfectant, or general cleaner.
Primary source
U.S. Food and Drug Administration

Researchers, Healthcare

Active moiety

The part of a substance responsible for the relevant biological or chemical activity, separate from salt-form naming.

This helps explain why databases may connect octenidine and octenidine hydrochloride records.
Primary source
PubChem, National Library of Medicine

Consumers, Healthcare

Product label

The official or manufacturer-provided text that defines a product's ingredients, intended use, warnings, and directions in a specific jurisdiction.

The label is the first place to check how a specific product is meant to be used.
Primary source
U.S. Food and Drug Administration , U.S. Food and Drug Administration

Healthcare, Consumers

Skin antisepsis

Use of an antiseptic on skin in a defined context, such as before a procedure or as part of a decolonization protocol, when supported by product labeling or protocol.

The details depend on the product, body site, and local instructions.
Primary source
PubMed Central

Healthcare, Consumers

Wound cleanser

A product or solution used in wound care to clean a wound; evidence and intended use vary by wound type and formulation.

Wound-care decisions should be made with a clinician, especially for chronic, deep, infected, or worsening wounds.
Primary source
NCBI Bookshelf

Healthcare, Consumers

Decolonization

A healthcare approach intended to reduce or remove carriage of certain microorganisms in defined patient or facility contexts.

This is usually a supervised healthcare protocol, not a general hygiene routine.
Primary source
PubMed Central

All readers

MRSA

Methicillin-resistant Staphylococcus aureus, a type of Staphylococcus aureus with resistance to some beta-lactam antibiotics.

MRSA topics should be handled as healthcare-context information, not self-treatment advice.
Primary source
PubMed Central

Healthcare, Consumers

Healthcare-associated infection

An infection associated with receiving care in a healthcare setting.

These topics involve clinical protocols and infection-prevention teams.
Primary source
PubMed Central

Healthcare

Surgical site infection

An infection occurring after surgery in the part of the body where the surgery took place, defined by clinical surveillance criteria.

Prevention depends on a bundle of clinical practices, not one product alone.
Primary source
PubMed Central

Healthcare

CLABSI

Central-line-associated bloodstream infection; a healthcare-associated infection measure tied to central venous catheters.

Central-line care is a clinical protocol topic.
Primary source
PubMed Central

Healthcare, Researchers

Biofilm

A structured community of microorganisms associated with a surface and embedded in a protective matrix.

Biofilm research is often laboratory-based, so clinical meaning must be stated carefully.
Primary source
National Library of Medicine

All readers

In vitro

Research performed outside a living organism, such as in a test tube, culture plate, or laboratory model.

In vitro findings do not automatically show what will happen in patients.
Primary source
Antimicrobial Agents and Chemotherapy / PubMed Central

All readers

Randomized controlled trial

A study design in which participants or units are assigned to intervention groups using randomization.

Randomization can reduce some kinds of bias, but trial results still depend on design and context.
Primary source
PubMed Central

All readers

Evidence synthesis

A structured summary of multiple studies, such as a systematic review or health technology assessment.

These sources help show whether findings are consistent or uncertain across studies.
Primary source
NCBI Bookshelf

All readers

Orphan designation

A regulatory status that can support development for rare conditions in a defined jurisdiction; it is not the same as marketing authorization.

A designation does not mean a medicine is approved for use.
Primary source
European Medicines Agency

Researchers

Maximum residue limit

A regulatory limit for residues in food products from animals exposed to a veterinary medicine or certain biocidal uses.

This is a veterinary and food-safety regulatory concept, not a consumer use instruction.
Primary source
European Medicines Agency

Researchers

EC number

A European Community identifier used in EU chemical substance systems.

It is useful for EU chemical regulatory lookup, not for medical advice.
Primary source
European Chemicals Agency

All readers

Adverse event

An unwanted medical occurrence reported during or after product exposure, whether or not causality is established.

Side-effect and adverse-event information depends on product, person, and context.
Primary source
NCBI Bookshelf

All readers

Off-label use

Use outside the conditions described in an approved product label or authorization.

Off-label topics should be discussed with a qualified professional, not inferred from general web information.
Primary source
U.S. Food and Drug Administration